LYDIA FRANKLIN: Open Payments
NPI 1083673792 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 51 payments from 8 companies in 2025. Trend: 2023 $558 · 2024 $736 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 21 | $253 |
| Alkermes, Inc. | 9 | $217 |
| Janssen Pharmaceuticals, Inc | 6 | $125 |
| E.R. Squibb & Sons, L.L.C. | 4 | $92 |
| Lundbeck LLC | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: INGREZZA, ARISTADA, ABILIFY ASIMTUFII, INVEGA SUSTENNA, COBENFY, FANAPT, CAPLYTA.
Industry payments across TN — which companies pay providers there.
